Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders
Scope & Guideline
Advancing research for better musculoskeletal health.
Introduction
Aims and Scopes
- Rheumatology and Inflammatory Diseases:
The journal extensively covers research related to rheumatological conditions such as rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthropathies, focusing on the pathophysiology, diagnosis, and treatment options. - Osteoarthritis and Joint Disorders:
A significant focus is placed on osteoarthritis, including novel therapeutic approaches, patient management strategies, and the evaluation of treatment outcomes. - Patient-Centered Outcomes and Quality of Life:
Research emphasizing patient-reported outcomes, quality of life assessments, and the psychological impact of musculoskeletal disorders is a key component, highlighting the importance of holistic patient care. - Novel Therapeutics and Interventions:
The journal includes studies on innovative treatment modalities, including biologics, pharmacotherapy, and emerging therapies such as prolotherapy and medical cannabis. - Epidemiology and Public Health:
Public health aspects, including the epidemiology of arthritis, the impact of obesity on joint health, and systemic health implications associated with musculoskeletal disorders, are also addressed.
Trending and Emerging
- Impact of Comorbidities on Musculoskeletal Disorders:
There is a rising emphasis on understanding how conditions such as obesity and metabolic syndrome affect the development and progression of arthritis, which is crucial for comprehensive patient management. - Psychosocial Factors and Mental Health:
Emerging themes related to the psychological aspects of living with arthritis, including depression, anxiety, and body image concerns, underscore the importance of addressing mental health in conjunction with physical health. - Innovative Non-Pharmacological Treatments:
A notable trend is the exploration of non-pharmacological therapies, such as prolotherapy and wearable technology for pain management, indicating a shift towards integrating alternative treatments into standard care. - COVID-19 Related Research:
The pandemic has catalyzed research on the implications of COVID-19 on patients with rheumatological diseases, highlighting the need for adaptations in treatment approaches during global health crises. - Patient-Reported Outcomes and Personalized Medicine:
An increasing focus on patient-reported outcome measures and personalized treatment strategies demonstrates a commitment to improving individual patient experiences and outcomes in musculoskeletal care.
Declining or Waning
- Traditional Surgical Interventions:
While surgical case reports and observational studies were previously common, there has been a noticeable decline in the publication of traditional surgical intervention studies, possibly due to a shift towards conservative management and novel therapeutic strategies. - Basic Science and Pathophysiology Studies:
Research focusing solely on the basic science aspects of arthritis and musculoskeletal disorders has decreased, indicating a possible trend towards more clinically relevant studies that emphasize treatment and patient outcomes. - Specific Case Reports with Limited Generalizability:
The prevalence of narrowly focused case reports, particularly those with limited applicability to broader clinical practice, has diminished, reflecting a preference for studies that offer wider insights into treatment efficacy and patient management.
Similar Journals
Pediatric Rheumatology
Connecting global experts to elevate pediatric health research.Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.
RMD Open
Advancing knowledge in Immunology and Rheumatology.RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.
Revista Cubana de Reumatologia
Transforming rheumatology through cutting-edge research.Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.
Orthopaedic Journal of Sports Medicine
Transforming Sports Medicine with Pioneering ResearchThe Orthopaedic Journal of Sports Medicine, published by SAGE Publications Inc, stands at the forefront of research in the fields of orthopedics and sports medicine. Since its establishment as an Open Access journal in 2013, it has committed to disseminating high-quality, peer-reviewed research that advances the understanding of musculoskeletal health and athletic performance. With a remarkable impact factor and ranked in the Q1 category for both orthopedic and sports medicine disciplines, the journal serves as a critical resource for researchers, clinicians, and practitioners eager to stay ahead in an evolving landscape. With its impressive Scopus ranking—positioned #89 out of 321—this journal is not only instrumental in fostering innovation but also essential for informing clinical practices and guiding future research avenues. The Orthopaedic Journal of Sports Medicine is dedicated to optimizing patient care and enhancing athletic performance, making it invaluable to the global community of sports medicine professionals and students.
CLINICAL AND EXPERIMENTAL DERMATOLOGY
Advancing Dermatological Science, One Study at a Time.CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.
BMC Rheumatology
Innovating insights for a healthier future in rheumatology.BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.
LUPUS
Elevating knowledge in lupus through impactful research.LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.
Rheumatology and Therapy
Bridging research and patient care in rheumatic diseases.Rheumatology and Therapy, published by Springer, stands as a prominent open-access journal within the fields of Immunology and Allergy and Rheumatology. Since its inception in 2014, the journal has made significant contributions to advancing the understanding, diagnosis, and treatment of rheumatic diseases, garnering a solid reputation with an impact factor that reflects its rigorous peer-review process and scholarly influence. Currently ranked in the Q2 quartile for both its categories according to 2023 metrics, it occupies a significant position among its peers, standing at Rank #21 out of 73 in Medicine Rheumatology and Rank #101 out of 233 for Medicine Immunology and Allergy. The journal's scope encompasses cutting-edge research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and patient care, making it an invaluable resource for researchers, clinicians, and students alike. With its commitment to open access, Rheumatology and Therapy ensures that high-quality research is available to a global audience, fostering collaboration and innovation in rheumatology and immunology. To learn more, visit their official site and explore the wealth of knowledge available.
JOINT BONE SPINE
Connecting research and practice in rheumatology and orthopedics.JOINT BONE SPINE is a premier peer-reviewed journal dedicated to advancing knowledge in the fields of rheumatology and orthopedics. Published by Elsevier France-Editions Scientifiques Medicales Elsevier, this esteemed journal has established itself as a key resource within the academic community, being categorized in the Q2 quartile of rheumatology journals for 2023. With an impressive impact as denoted by its Scopus rank of #26 out of 73, and a noteworthy 65th percentile, JOINT BONE SPINE serves as a vital platform for innovative research and clinical findings that address bone and joint diseases. The journal promotes open access, which enhances the dissemination of research findings, ensuring that practitioners, researchers, and students alike can easily access the latest developments and methodologies in the field. With a commitment to bridging scientific advances from 2000 to the present and beyond, JOINT BONE SPINE plays a critical role in shaping the future of musculoskeletal medicine and improving patient outcomes worldwide.
Therapeutic Advances in Musculoskeletal Disease
Empowering Clinicians with Cutting-edge InsightsTherapeutic Advances in Musculoskeletal Disease is a premier, peer-reviewed journal published by SAGE Publications Ltd, focusing on the latest advancements in the understanding and treatment of musculoskeletal disorders. Since becoming an Open Access journal in 2019, it has significantly broadened its reach, providing researchers, clinicians, and practitioners with unfettered access to high-quality studies and reviews from 2009 to 2024. With an impressive impact factor reflected by its Q1 rank in Orthopedics and Sports Medicine and Q2 rank in Rheumatology for 2023, the journal occupies a critical position within its field. Ranked #31 out of 321 in Orthopedics and Sports Medicine and #17 out of 73 in Rheumatology on Scopus, it emphasizes both the clinical and scientific aspects of musculoskeletal health. This journal serves as a vital resource for advancing knowledge, encouraging collaboration, and fostering innovative treatment methods within the musculoskeletal community.